CIK 0001661998
- Non-accelerated filer
- Smaller reporting company
Q32 Bio Inc.
Sign in to watch- Ticker
- QTTB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 473468154
- Phone
- +1 781-999-0232
- Business address
- 830 WINTER STREET, WALTHAM, MA, 02451
- Former names
- Q32 Bio Inc., Homology Medicines, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $320,396
- in 6 filings
Net −$320,396. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-14 | PARMAR KUSH Director | Sale | −151,138 | $13.06 | $2.0M | 5,163,346 |
| 2020-12-14 | PARMAR KUSH Director | Sale | −328,862 | $11.88 | $3.9M | 4,834,484 |
| 2020-12-14 | PARMAR KUSH Director | Sale | −6,297 | $13.06 | $82K | 215,138 |
| 2020-12-14 | PARMAR KUSH Director | Sale | −13,703 | $11.88 | $163K | 201,435 |
| 2020-12-14 | 5AM Ventures IV, L.P. 10% owner | Sale | −151,138 | $13.06 | $2.0M | 5,163,346 |
| 2020-12-14 | 5AM Ventures IV, L.P. 10% owner | Sale | −328,862 | $11.88 | $3.9M | 4,834,484 |
| 2020-12-14 | 5AM Ventures IV, L.P. 10% owner | Sale | −6,297 | $13.06 | $82K | 215,138 |
| 2020-12-14 | 5AM Ventures IV, L.P. 10% owner | Sale | −13,703 | $11.88 | $163K | 201,435 |
| 2020-07-21 | Poulton Jeffrey V. Director | Grant or award · Option (Right to Buy) | +36,000 | 36,000 | ||
| 2020-06-10 | REICIN ALISE Director | Grant or award · Option (Right to Buy) | +18,000 | 18,000 | ||
| 2020-06-10 | PARMAR KUSH Director | Grant or award · Option (Right to Buy) | +18,000 | 18,000 | ||
| 2020-06-10 | Gregory Richard J. Director | Grant or award · Option (Right to Buy) | +18,000 | 18,000 | ||
| 2020-06-10 | Thistle Mary Director | Grant or award · Option (Right to Buy) | +18,000 | 18,000 | ||
| 2020-06-10 | Patterson Matthew R Director | Grant or award · Option (Right to Buy) | +18,000 | 18,000 | ||
| 2020-06-10 | GILLIS STEVEN Director | Grant or award · Option (Right to Buy) | +18,000 | 18,000 | ||
| 2020-03-17 | Kelly Timothy P | Sale | −1,315 | $13.01 | $17K | 0 |
| 2020-02-03 | Smith W Bradford CFO, Treasurer & Secretary | Exercise or conversion | +12,000 | $0.63 | $8K | 12,000 |
| 2020-02-03 | Smith W Bradford CFO, Treasurer & Secretary | Sale | −12,000 | $16.16 | $194K | 0 |
| 2020-02-03 | Smith W Bradford CFO, Treasurer & Secretary | Exercise or conversion · Employee Stock Option | −12,000 | 103,404 | ||
| 2020-02-03 | TZIANABOS ARTHUR President & CEO | Sale | −12,500 | $16.16 | $202K | 77,505 |
Page 17 of 25 · 492 trades